Senology.org - Newsletter

International Senologic and Oncologic  Scientific Community (ISOSC) 

"Connecting specialists worldwide"

 Editor-in-Chief: Gian Paolo Andreoletti, MD

Join us on  LinkedInTwitter, Facebook, ResearchGateDoctorsbook, Google Groups, YouTube, SlideShare, Flickr, and share informations and opinions.  Read the Senology.org Newspaperdaily

 

Senology.org collaborates with 

 "Cancer questions, answers, and support". Follow the Expert Q&A Workshops and join the conversation

 

Literature Selection

Comment

Discussion

  "For patients with ER-positive breast cancer, continuing tamoxifen to 10 years rather stopping at 5 years reduces recurrence and mortality" - Share your opinion on LinkedIn

Questions and Answers 

Fragments of History

Calendar of Events

Literature Selection

Questions and Answers 

Literature Selection

Questions and Answers 

Subscribe          Unsubscribe          Contact          Back Issues

     

www.senology.org